Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients

por Gagelmann, Nico, Ayuk, Francis A., Klyuchnikov, Evgeny, Wolschke, Christine, Berger, Susanna Carolina, Kröger, Nicolaus
Publicado 2023

Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model

por Berger, S Carolina, Sommermeyer, Daniel, Hudecek, Michael, Berger, Michael, Balakrishnan, Ashwini, Paskiewicz, Paulina, Kosasih, Paula, Rader, Christoph, Riddell, Stanley
Publicado 2014

Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy

por Berger, Susanna Carolina, Fehse, Boris, Akyüz, Nuray, Geffken, Maria, Wolschke, Christine, Janson, Dietlinde, Gagelmann, Nico, Luther, Marlene, Wichmann, Dominic, Frenzel, Christian, Thayssen, Guenther, Alegiani, Anna, Badbaran, Anita, Zeschke, Silke, Dierlamm, Judith, Kröger, Nicolaus, Ayuk, Francis A.
Publicado 2022